Sonic Healthcare Limited (ASX: SHL)

Market Cap	13.05B
Revenue (ttm)	8.97B
Net Income (ttm)	511.09M
Shares Out	480.20M
EPS (ttm)	1.07
PE Ratio	25.35
Forward PE	24.85
Dividend	1.06 (3.90%)
Ex-Dividend Date	Sep 4, 2024

Volume	1,950,062
Open	27.44
Previous Close	27.50
Day's Range	27.04 - 27.60
52-Week Range	23.58 - 32.57
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 14, 2025

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomograph...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 42,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SHL

Financial Performance

In 2024, Sonic Healthcare's revenue was 8.97 billion, an increase of 9.77% compared to the previous year's 8.17 billion. Earnings were 511.09 million, a decrease of -25.39%.